Profile of serum and urinary electrolytes in critically ill patients
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Mortality
研究概览
简要总结
Introduction:Intensive care unit (ICU) services require expensive technology, and account for as much as 10 percent of all health care costs. The outcome of critically ill patients is therefore of importance not only to the patients and their families, but also to the society. After admission to the ICU, the outcome is dependent upon both the diagnosis and management of the primary illness and, in many cases, the presence or absence of multi-organ involvement.1On the other hand, electrolytes such as potassium, sodium, chloride, magnesium, calcium and phosphate play important roles in cellular metabolism and energy transformation, and in the regulation of cell membrane potentials, especially those of muscle and nerve cells, which demonstrate their important role in the outcome of critically ill patients. Depletion of these electrolytes can induce a wide range of clinical disorders, including neuromuscular dysfunction and severe arrhythmias. The risk for these disorders increases significantly when more than one electrolyte is deficient.2It is well known that hypokalemia can induce cardiac arrhythmias (especially in patients with ischemic heart disease and left ventricular hypertrophy), and that it is associated with other adverse effects such as muscle weakness, rhabdomyolysis, renal failure and hyperglycemia. Additionally, hyperkalemia may cause symptoms such as severe muscle weakness or paralysis and cardiac conduction abnormality which may lead to adverse outcomes in ill ICU patients.3-6Moreover, hyponatremia is a common electrolyte abnormality in critically ill patients.6-9The risk of hyponatremia among hospitalized patients is influenced by the underlying disease state and clinical circumstances. Another sodium disturbance, hypernatremia, is basically a mirror image of hyponatremia6,10-12and can cause rupture of the cerebral veins, leading to focal intracerebral and subarachnoid hemorrhages and possible irreversible neurologic damage. The clinical manifestations of this disorder begin with lethargy, weakness, and irritability, and can progress to twitching, seizures, and comaThe importance of regulating potassium and sodium levels is well recognized in most intensive care units (ICUs) and the development of many electrolyte disturbances in the ICU can be prevented by attention to the usual intravenous fluids and nutrition. On the other hand, chloride levels have not been studied extensively. Chloride is the most abundant anion in the extracellular fluid and constitutes approximately one-third of the extracellular fluid tonicity.13Chloride plays a pivotal role in many body functions including acid-base balance, muscular activity, osmosis, and immunomodulation.14Despite its physiological importance, chloride has captured little attention by the scientific community until recently15when chloride-rich solutions were associated with hyperchloremic metabolic acidosis16,17and short-term mortality after non-cardiac surgery.18,19The most common chloride-rich solution utilized in clinical practice is 0.9% saline20, particularly in critical illness and perioperatively. 0.9% saline is in reality a non-neutral solution21and has a supraphysiologic amount of chloride when compared to plasma (154 vs ~100 mEq/L, respectively).22,23The consequent hyperchloremic metabolic acidosis derived from the liberal use of chloride-rich solutions has been described as a common but poorly recognized disorder in critically ill patients24,25, with numerous detrimental consequences26,27, particularly in those with severe sepsis and septic shock.28The purpose of our study was to determine whether there was an independent association of serum and urinary electrolyte levels at 2 different time points of ICU stay with hospital mortality in critically ill septic patients. The 2 evaluated time points were ICU admission (t0) and at 48-72 h of ICU stay (t72). Objectives· To evaluate the profile of serum and urinary electrolytes in critically ill patients.
· To study the association of serum and urinary electrolytes with short-term mortality in critically ill patients
· To evaluate any association between serum and urinary electrolytes and Acute Kidney Injury in critically ill patients.
Methodology:All critically ill patients admitting in the Medical ICU of Dr. Pinnamaneni Siddhartha Institute of Medical Sciences & RF will be screened for inclusion in the study. Participants/Attendants if willing for the study, and who have reports of serum electrolytes performed within three hours of admission to the ICU will be enrolled.The baseline characteristics such as Age, Gender, history of Diabetes Mellitus, Hypertension, Cardiac disease, kidney disease, smoking and alcohol history will be obtained. The patient’s diagnosis will be noted from the medical records. The subjects blood pressure (BP) will be recorded from the medical records. The reports of the following investigations done within 3 hours of ICU admission will be collected: Hemoglobin (Hb), Random blood sugar (RBS), serum creatinine, serum electrolytes (sodium, potassium, chloride), Calcium, Phosphorous, Total Bilirubin, serum Albumin and Arterial Blood Gas analysis. Patients with incomplete reports will be excluded from the study. The patients spot urinary electrolytes and urinary creatinine will be measured (t0). Serum and urinary electrolytes will be repeated again between 48-72 hours after admission (t72). Biochemical investigations will be done as per the standard hospital methodology. eGFR will be calculated using CKD-EPI equation. Lower levels of laboratory reference values will be used as the cutoff points for clinically significant electrolyte depletion, and the upper levels as cutoff points for significant increase in electrolyte concentration. The patients will be followed up and the development of AKI, cumulative fluid balance in ICU, in-ICU mortality, in-hospital mortality, duration of ICU stay and duration of hospital stay will be recorded. The patients will be contacted and followed up at three months to identify mortality upto three months.References:
1. Sedlacek M, Schoolwerth AC, Remillard BD. Electrolyte disturbances in the intensive care unit. Semin Dial 2006; 19 (6): 496- 501.
2. Ducceschi V, D’Andrea A, Liccardo B, Sarubbi B, Ferrara L, Romano GP, et al. Ventricular tachyarrhythmias following coronary surgery: predisposing factors. Int J Cardiol 2000; 73 (1): 43- 8.
3. Muensterer OJ. Hyperkalaemic paralysis. Age Ageing 2003; 32 (1): 114- 5.
4. Livingstone IR, Cumming WJ. Hyperkalaemic paralysis resembling Guillain-Barré syndrome. Lancet 1979; 2 (8149): 963- 4.
5. Bashour T, Hsu I, Gorfinkel HJ, Wickramesekaran R, Rios JC. Atrioventricular and intraventricular conduction in hyperkalemia. Am J Cardiol 1975; 35 (2): 199- 203.
6. Lee JW. Electrolyte Blood Press. 2010 Dec;8(2):72-81. Fluid and electrolyte disturbances in critically ill patients.
7. Friedman B, Cirulli J. Hyponatremia in critical care patients: Frequency, outcome, characteristics, and treatment with the vasopressin V(2)-receptor antagonist tolvaptan. J Crit Care 2012.
8. Amin A, Deitelzweig S, Christian R, Friend K, Lin J, Belk K, et al. Evaluation of incremental healthcare resource burden and readmission rates associated with hospitalized hyponatremic patients in the US. J Hosp Med 2012; 7 (8): 634- 9.
9. Mannesse CK, Vondeling AM, van Marum RJ, van Solinge WW, Egberts TC, Jansen PA. Prevalence of hyponatremia on geriatric wards compared to other settings over four decades: A systematic review. Ageing Res Rev 2012; 12 (1): 165- 173.
10.Rose BD, Post TW. Clinical Physiology of Acid-Base and Electrolyte Disorders, 5th ed, McGraw-Hill, New York, 2001, pp. 716-720, 761-764.
11.Strange K. Regulation of solute and water balance and cell volume in the central nervous system. J Am Soc Nephrol 1992; 3 (1): 12- 27.
12.Adrogué HJ, Madias NE. Hypernatremia. N Engl J Med 2000; 342 (20): 1493- 9.
13.Hall, JE.; Guyton, AC. Guyton and Hall textbook of medical physiology. 12. Philadelphia, Pa: Saunders/Elsevier; 2011.
14.Berend K, van Hulsteijn LH, Gans RO. Chloride: the queen of electrolytes? Eur J Intern Med. 2012; 23(3):203–211.
15.Yunos NM, Bellomo R, Story D, et al. Bench-to-bedside review: Chloride in critical illness. Critical care. 2010; 14(4):226.
16.Scheingraber S, Rehm M, Sehmisch C, et al. Rapid saline infusion produces hyperchloremic acidosis in patients undergoing gynecologic surgery. Anesthesiology. 1999; 90(5):1265–1270.
17.Mann C, Held U, Herzog S, et al. Impact of normal saline infusion on postoperative metabolic acidosis. Paediatr Anaesth. 2009; 19(11):1070–1077.
18.Silva JM Junior, Neves EF, Santana TC, et al. The importance of intraoperative hyperchloremia. Rev Bras Anestesiol. 2009; 59(3):304–313.
19.McCluskey SA, Karkouti K, Wijeysundera D, et al. Hyperchloremia after noncardiac surgery is independently associated with increased morbidity and mortality: a propensity-matched cohort study. Anesth Analg. 2013; 117(2):412–421.
20.Powell-Tuck, J.; Gosling, P.; Lobo, DN., et al. British Consensus Guidelines on Intravenous Fluid Therapy for Adult Surgical Patients (GIFTASUP). The British Association for Parenteral and Enteral Nutrition (BAPEN); 2008. (updated 2011). Available at http://www.bapen.org.uk/pdfs/ bapen_pubs/giftasup.pdf
21.Story DA, Thistlethwaite P, Bellomo R. The effect of PVC packaging on the acidity of 0. 9% saline. Anaesth Intensive Care. 2000; 28(3):287–292.
22.Guidet B, Soni N, Della Rocca G, et al. A balanced view of balanced solutions. Critical care. 2010; 14(5):325.
23.Veech RL. The toxic impact of parenteral solutions on the metabolism of cells: a hypothesis for physiological parenteral therapy. Am J Clin Nutr. 1986; 44(4):519–551.
24.Moviat M, van den Boogaard M, Intven F, et al. Stewart analysis of apparently normal acid-base state in the critically ill. J Crit Care. 2013; 28(6):1048–1054.
25.O’Dell E, Tibby SM, Durward A, et al. Hyperchloremia is the dominant cause of metabolic acidosis in the postresuscitation phase of pediatric meningococcal sepsis. Crit Care Med. 2007; 35(10):2390–2394.
26.Lobo DN, Awad S. Should chloride-rich crystalloids remain the mainstay of fluid resuscitation to prevent ’pre-renal’ acute kidney injury?: con. Kidney Int. 2014; 86(6):1096–1105.
27.Krajewski ML, Raghunathan K, Paluszkiewicz SM, et al. Meta-analysis of high- versus low- chloride content in perioperative and critical care fluid resuscitation. Br J Surg. 2015; 102(1):24– 36.
28.Noritomi DT, Soriano FG, Kellum JA, et al. Metabolic acidosis in patients with severe sepsis and septic shock: a longitudinal quantitative study. Crit Care Med. 2009; 37(10):2733–2739.
29.Mousavi SAJ, Shahabi S, Mostafapour E, Purfakharan M, Fereshtehnejad SM, Amini J et al. Comparision of the serum electrolyte levels among patients died and survived in the intensive care unit. Tanaffos 2012; 11(4): 36-42.
30.Panda I, Save S. Study of association of mortality with electrolyte abnormalities in children admitted in pediatric intensive care unit. Int J Contemp Pediatr 2018; 5(3): 1097-1103.
31.Neyra JA, Canepa-Escaro F, Li X, Manllo J, Adams-Huet B, Yee J et al. Association of hyperchloremia with hospital mortality in critically ill septic patients. Crit Care Med 2015; 43(9): 1938-1944.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 99.00 Year(s)(—)
- 性别
- All
入选标准
- •1.Age 18 years and above.
- •2.Critically ill patients admitted to the Medical ICU.
排除标准
- •1.Age less than 18 years 2.Patients not willing to participate 3.Pregnant women 4.Patients admitted to Surgical ICU.
结局指标
主要结局
Mortality
时间窗: At hospital discharge
次要结局
- Duration of ICU stay(At hospital discharge)
- Duration of hospital stay(At hospital discharge)
